PFKFB3, a key glycolytic enzyme, is upregulated in tumor-associated monocytes, and leads to the activation of glycolysis, and this can induce PD-L1 expression, and subsequently attenuate the response of cytotoxic T lymphocyte in tumor tissues [107]. This evidence concerns the gene PFKFB3 and neoplasm.